Sepehr Rejai, M.D. Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2850 Telegraph Ave Ste 120, Berkeley, CA 94705 Phone: 510-204-8140 Fax: 510-506-7721 |
Dr. Zachary Clifford Landman, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2850 Telegraph Ave Ste 120, Berkeley, CA 94705 Phone: 510-204-8140 Fax: 510-506-7721 |
Edward Manougian, M.D. Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1517 Summit Rd, Berkeley, CA 94708 Phone: 510-843-9247 Fax: 510-843-9247 |
News Archive
University of Kentucky College of Pharmacy Professor Chang-Guo Zhan, along with fellow UK Professors Fang Zheng and Sharon Walsh, and Professor Mei-Chuan Ko from Wake Forest University, recently received $6 million in funding over five years to further develop a potential treatment for cocaine abuse.
Developing countries Monday at a meeting in Istanbul said they should get larger percentages of the vote at the World Bank and the International Monetary Fund (IMF), the Associated Press reports.
Obesity is caused by numerous and complex factors, some of which are as yet unsuspected. Scientists from the CNRS, INSERM, UPMC and Université Paris Descartes, working with research clinicians from Paris Public Hospitals (AP-HP) have now shown that severe obesity is accompanied by inflammation of the small intestine and enhanced immune response in that region.
Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA) for its product candidate Nefecon (PL-56) for patients with IgA nephropathy, also referred to as Berger's Disease. This program is presently in clinical development phase II.
Scientists at the Gladstone Institutes have discovered that a certain type of DNA damage long thought to be particularly detrimental to brain cells can actually be part of a regular, non-harmful process.
› Verified 4 days ago